
Sign up to save your podcasts
Or


In the latest edition of our Between Two Fools interview series, Fool.com contributor Matt Frankel, CFP sits down for an interview with Steve Streit, founder and CEO of Green Dot Corporation (NYSE: GDOT). Plus, Frankel and host Jason Moser dive intoSquare’s (NYSE: SQ) recent earnings release and the surprise announcement of the sale of its Caviar foodservice platform, and also take a look at Capital One’s (NYSE: COF) data breach and what it could mean for investors. All of this and the stocks we’re watching now in this week’s episode of Industry Focus: Financials.
Check out more of our content here:
Online education business 2U reported earnings this week, and while the past quarter's numbers were fine it seems like the growth story for the company might be changing. Simon Erickson, lead advisor of Motley Fool Explorer joins us to explain what's going on at 2U and why the stock sold off over 60%.
Check out more of our content here:
Thanks to Molekule for supporting our channel. Get $75 off your first order at http://www.molekule.com code fool75.
Social and environmental issues have become more and more important in recent years, and investing hasn’t been spared from this trend. As a result, there has been a steady increase in investing based on Environmental, Social, and Governance factors, commonly known as ESG investing. Although ESG is growing in importance, many investors are still unaware of its existence. Motley Fool Analyst Maria Gallagher joins the show to introduce investors to ESG and share one of her favorite ESG investments, Trex.
Stocks Mentioned: TREX
Articles Mentioned:
The Motley Fool’s ESG Hub
The Motley Fool’s ESG Investing Framework
ESG Investing: Is Trex a Responsible Investment
Check out more of our content here:
Pot stock HEXO is under fire over its use of social media advertising and if that isn't bad enough, its home province, Quebec, has proposed restrictions on marijuana edibles that could disrupt its growth plans. Is it game over for HEXO? Also, here's why biopharma giant Pfizer is merging its off-patent drug portfolio with generic drug heavy weight Mylan.
Check out more of our content here:
On this week’s episode of Industry Focus: Consumer Goods host Jason Moser and Fool.com contributor Dan Kline take a look at the most recent quarters for Beyond Meat and Under Armour and drill down into Amazon's most recent Prime Day results and what it all really means for the company!
Check out more of our content here:
We’ve now heard the latest results from most of the major U.S. banks, so in this episode of Industry Focus: Financials, host Jason Moser and Fool.com contributor Matt Frankel, CFP break down what investors need to know. Plus, they dig into the War on Cash and how cryptocurrencies could potentially affect some of our favorite payments companies, and each gives us one of their favorite foreign fintech companies to keep an eye on. All of this and more on this week’s installment.
Check out more of our content here:
Thanks to a strong earnings report, Snap is finally back to the valuation it went public at several years ago. With users joining the platform, should investors be interested in shares? We talk about that, and Facebook's earnings release and the impact of the FTC's fine.
We’re diving into the auto industry this week. With Ford reporting earnings Wednesday night, Motley Fool Contributor John Rosevear joins the show to break down the report and discuss Ford’s expanded partnership with Volkswagen focused around electric and autonomous vehicles. On the back half of the show, we take a look at negotiations beginning between the Big Three US Automakers and the United Auto Workers (UAW). Stay tuned to the end of the show to hear us all (including Dan Boyd) weigh in on Chevy’s new mid-engine Corvette.
Stocks Mentioned: F, VWAPY, GM, FCAU,
Check out more of our content here:
StockUp, The Motley Fool's weekly email newsletter
Podcasts
Youtube
Reach us by Email @ [email protected]
$50 off your first job post. Linkedin.com/fool
Marijuana stock CannTrust has revealed its been growing pot in unlicensed rooms, calling into question its future as a cannabis leader. Also, here’s why Gilead Sciences’ CEO just inked a multibillion deal with Galapagos to develop drugs together.
The two biggest players in the cruise industry -- Carnival and Royal Caribbean -- have both generally performed well. The two companies, however, are in a bit of an arms race -- adding new ships with increasingly impressive features -- think ice skating rinks, laser tag, and robot-run bars just to start -- when questions exist as to whether younger people will want to cruise. Both companies have taken steps to market to younger generations and, so far, the numbers look good but as is the case on any cruise, a storm could be coming.
From the publisher's feed

3,161 Listeners

807 Listeners

933 Listeners

1,604 Listeners